Assyro AI

Orange Book product · Brand (NDA)

LEVULAN

AMINOLEVULINIC ACID HYDROCHLORIDE

Brand (NDA)NDA 020965RX SUN PHARM INDS INC

At a glance

Dec 03, 1999

Approved

Brand (NDA)

Application

Not listed

TE code

10

Listed patents

Key dates

  1. Approval

    FDA approval date of this drug product.

    Dec 03, 1999

    26 yr 11 mo ago

  2. Today

  3. Patent 11179574 expires

    Listed method-of-use patent (U-804) expiration.

    Oct 13, 2036

    in 10 yr 6 mo

  4. Patent 11697028 expires

    Listed method-of-use patent (U-804) expiration.

    Oct 13, 2036

    in 10 yr 6 mo

  5. Patent 12290700 expires

    Listed method-of-use patent (U-804) expiration.

    Oct 13, 2036

    in 10 yr 6 mo

  6. Patent 11446512 expires

    Listed method-of-use patent (U-804) expiration.

    Jan 17, 2037

    in 10 yr 9 mo

  7. Patent 10357567 expires

    Listed method-of-use patent (U-3163) expiration.

    Jan 12, 2038

    in 11 yr 9 mo

  8. Patent 11077192 expires

    Listed method-of-use patent (U-3163) expiration.

    Jan 12, 2038

    in 11 yr 9 mo

  9. Patent 11135293 expires

    Listed method-of-use patent (U-3163) expiration.

    Jan 12, 2038

    in 11 yr 9 mo

  10. Patent 11571478 expires

    Listed method-of-use patent (U-3163) expiration.

    Jan 12, 2038

    in 11 yr 9 mo

  11. Patent 11690914 expires

    Listed method-of-use patent (U-3163) expiration.

    Jan 12, 2038

    in 11 yr 9 mo

  12. Patent 12296011 expires

    Listed method-of-use patent (U-3163) expiration.

    Jan 12, 2038

    in 11 yr 9 mo

Pharmaceutical detail

Active ingredient

AMINOLEVULINIC ACID HYDROCHLORIDE

Strength

20%

Dosage form

SOLUTION

Route

TOPICAL

TE code

Not listed

Application

NDA 020965

Product number

001

Marketing status

RX

Reference listed drug (RLD)

Yes

Reference standard (RS)

Yes

Active-ingredient family

View full family

This is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.

Listed patents (10)

Patents listed in the FDA Orange Book for this product, with expiration date and patent type.
PatentExpiresInType
11179574Oct 13, 2036in 10 yr 6 mo
U-804
11697028Oct 13, 2036in 10 yr 6 mo
U-804
12290700Oct 13, 2036in 10 yr 6 mo
U-804
11446512Jan 17, 2037in 10 yr 9 mo
U-804
10357567Jan 12, 2038in 11 yr 9 mo
U-3163
11077192Jan 12, 2038in 11 yr 9 mo
U-3163
11135293Jan 12, 2038in 11 yr 9 mo
U-3163
11571478Jan 12, 2038in 11 yr 9 mo
U-3163
11690914Jan 12, 2038in 11 yr 9 mo
U-3163
12296011Jan 12, 2038in 11 yr 9 mo
U-3163
Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.